The citrus flavonoid nobiletin enhances insulin sensitivity and decreases hepatic steatosis without AMPK activation, instead influencing the LXR and SREBP-1c pathways to suppress hepatic lipogenesis [124]. This evidence concerns the gene INS and fatty liver disease.